Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 28, 2023. (Total: 221530Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Primary Myelofibrosis and U2AF1[original query]
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
British journal of haematology 2015 Apr 169 (1): 71-6.
Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations.
Blood cancer journal 2016 6 e416.
Barraco D, Elala Y C, Lasho T L, Begna K H, Gangat N, Finke C, Hanson C A, Ketterling R P, Pardanani A, Tefferi
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations.
Blood cancer journal 2016 6 e415.
Barraco D, Elala Y C, Lasho T L, Begna K H, Gangat N, Finke C, Hanson C A, Ketterling R P, Pardanani A, Tefferi
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
British journal of haematology 2016 Nov 175 (3): 419-426.
Delic Sabit, Rose Dominic, Kern Wolfgang, Nadarajah Niroshan, Haferlach Claudia, Haferlach Torsten, Meggendorfer Man
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis.
Journal of hematology & oncology 2017 05 10 (1): 99.
Li Bing, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Song Zhen, Zhang Peihong, Bai Jie, Zhang Lei, Zhang Yue, Liu Jinqin, Huang Gang, Xiao Zhiji
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
American journal of hematology 2021 (7): 781-789.
Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis.
International journal of hematology 2021 Jan .
Morishita Soji, Ochiai Tomonori, Misawa Kyohei, Osaga Satoshi, Inano Tadaaki, Fukuda Yasutaka, Edahiro Yoko, Ohsaka Akimichi, Araki Marito, Komatsu Nor
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression.
European journal of haematology 2021 1 106 (4): 520-528.
Bartels Stephan, Vogtmann Julia, Schipper Elisa, Büsche Guntram, Schlue Jerome, Lehmann Ulrich, Kreipe Ha
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.
Frontiers in oncology 2023 8 13 1190305.
Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
British journal of haematology 2023 5 .
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun V Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref Al-Ka
TOP